Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase
Titel:
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase
Auteur:
Giles, Francis J. Feldman, Eric J. Roboz, Gail J. Larson, Richard A. Mamus, Steven W. Cortes, Jorge E. Verstovsek, Srdan Faderl, Stefan Talpaz, Moshe Beran, Miloslav Albitar, Maher O’Brien, Susan M. Kantarjian, Hagop M.